borderline significancep = 0.052
Indeed, the TORCH study demonstrated a 17.5% reduction of risk of death with a borderline significance ( p = 0.052) in favour of ICS/LABA treatment versus placebo [ 160 ].
Indeed, the TORCH study demonstrated a 17.5% reduction of risk of death with a borderline significance ( p = 0.052) in favour of ICS/LABA treatment versus placebo [ 160 ].